Remedent

Remedent CROIC

The Cash Return on Invested Capital (CROIC) of Remedent (REMI) as of Nov 5, 2026 is -5.68 %. In the previous year, Cash Return on Invested Capital (CROIC) was -2.02 % — a change of 181.64% (lower).

CROIC

-5.68 %

YoY

181.64%

Last updated:

Cash Return on Invested Capital (CROIC) of Remedent is 2024 -5.68 % . Cash Return on Invested Capital (CROIC) of Remedent was 2023 -2.02 % . It decreases by 181.64% lower compared to the previous year.

The Remedent CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2017
52.40 USD
Jan 1, 2018
0.48 USD
Jan 1, 2019
10.43 USD
Jan 1, 2020
2.23 USD
Jan 1, 2021
0.04 USD
Jan 1, 2022
-4.09 USD
Jan 1, 2023
-2.02 USD
Jan 1, 2024
-5.68 USD
The Remedent CROIC history
YEARCROICYoY
-5.68 %+181.64%
-2.02 %-50.67%
-4.09 %-10,404.40%
0.04 %-98.22%
2.23 %-78.61%
10.43 %+2,059.25%
0.48 %-99.08%
52.40 %-822.68%
-7.25 %-607.79%
1.43 %-137.37%
-3.82 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Remedent Stock analysis

What does Remedent do? Remedent Inc is a company specialized in the development, manufacturing, and marketing of innovative dental products. It was founded in 1997 by Jürgen Steenwelle and Philippe de Bergeyck, with its headquarters in Mariakerke, Belgium. The company started with the creation of the GlamSmile veneer system, which revolutionized aesthetic dentistry. Remedent expanded its product portfolio to include teeth whitening systems, dental implants, dental instruments, and dental software solutions. The company aims to revolutionize the dental market with innovative technologies and materials. Remedent works closely with dental professionals worldwide to ensure the highest quality standards. It has locations in Europe, the USA, and Asia. Partnership with dentists and clinics is a key aspect of Remedent's business model, offering training and certifications to ensure proper and effective use of their products. The company is focused on global market expansion through strategic acquisitions and mergers to grow its customer base and promote technological advancements. Remedent has achieved impressive growth and success in a highly competitive market, remaining a significant provider of dental products and pursuing a strong growth strategy. Remedent is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Remedent stock

Cash Return on Invested Capital (CROIC) of Remedent is -5.68 % in 2024.

Cash Return on Invested Capital (CROIC) of Remedent changed from -2.02 % to -5.68 %, representing a 181.64% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Remedent since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Remedent with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Remedent

All Key Metrics — Remedent